Adiponectin gene polymorphisms are associated with increased susceptibility to diabetic peripheral neuropathy

References

• Ando T, Ishikawa T, Takagi T, et al. (2013). Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter 18:158–64
   PubMed Web of Science ®Google Scholar
• Chen X, Xiang YB, Long JR, et al. (2012). Genetic polymorphisms in obesity-related genes and endometrial cancer risk. Cancer 118:3356–64
   PubMed Web of Science ®Google Scholar
• Chung CM, Lin TH, Chen JW, et al. (2011). A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes 60:2417–23
   PubMed Web of Science ®Google Scholar
• El Boghdady NA, Badr GA. (2012). Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct 30:328–34
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Mansournia N, Nakhjavani M, et al. (2012). Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep 39:3791–7
   PubMed Web of Science ®Google Scholar
• Hsiao TJ, Wu LS, Huang SY, et al. (2010). A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity. Clin Pharmacol 2:105–10
   PubMedGoogle Scholar
• Hu E, Liang P, Spiegelman BM. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697–703
   PubMed Web of Science ®Google Scholar
• Inanir A, Basol N, Karakus N, et al. (2013). The importance of association between angiotensin-converting enzyme (ACE) Gene I/D polymorphism and diabetic peripheral neuropathy. Gene 530:253–6
   PubMed Web of Science ®Google Scholar
• Jeong HG, Min BJ, Lim S, et al. (2012). Plasma adiponectin elevation in elderly individuals with subsyndromal depression. Psychoneuroendocrinology 37:948–55
   PubMed Web of Science ®Google Scholar
• Ji ZY, Li HF, Lei Y, et al. (2015). Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients. J Diabetes Complications 29:887–92
   PubMed Web of Science ®Google Scholar
• Kawasaki E, Maruyama T, Imagawa A, et al. (2014). Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig 5:115–18
   PubMed Web of Science ®Google Scholar
• Kim B, Feldman EL. (2012). Insulin resistance in the nervous system. Trends Endocrinol Metab 23:133–41
   PubMed Web of Science ®Google Scholar
• Lupachyk S, Watcho P, Stavniichuk R, et al. (2013). Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes 62:944–52
   PubMed Web of Science ®Google Scholar
• Nischal PM. (2014). World Medical Association publishes the Revised Declaration of Helsinki. Natl Med J India 27:56
   Web of Science ®Google Scholar
• Mete T, Aydin Y, Saka M, et al. (2013). Comparison of efficiencies of Michigan neuropathy screening instrument, neurothesiometer, and electromyography for diagnosis of diabetic neuropathy. Int J Endocrinol 2013:821745
   PubMed Web of Science ®Google Scholar
• Monastiriotis C, Papanas N, Veletza S, et al. (2012). APOE gene polymorphisms and diabetic peripheral neuropathy. Arch Med Sci 8:583–8
   PubMed Web of Science ®Google Scholar
• O'Brien PD, Hinder LM, Sakowski SA, et al. (2014). ER stress in diabetic peripheral neuropathy: a new therapeutic target. Antioxid Redox Signal 21:621–33
   PubMed Web of Science ®Google Scholar
• Papanas N, Katsiki N, Papatheodorou K, et al. (2011). Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62:291–5
   PubMed Web of Science ®Google Scholar
• Papanas N, Ziegler D. (2011). New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications 25:44–51
   PubMed Web of Science ®Google Scholar
• Ponirakis G, Petropoulos IN, Fadavi H, et al. (2014). The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy. Diabet Med 31:1673–80
   PubMed Web of Science ®Google Scholar
• Potter CS, Wang Z, Silva KA, et al. (2014). Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. PLoS One 9:e85666
   PubMed Web of Science ®Google Scholar
• Razazian N, Baziyar M, Moradian N, et al. (2014). Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial. Neurosciences (Riyadh) 19:192–8
   PubMed Web of Science ®Google Scholar
• Scherer PE, Williams S, Fogliano M, et al. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–9
   PubMed Web of Science ®Google Scholar
• Siitonen N, Pulkkinen L, Lindstrom J, et al. (2011). Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 12:5
   PubMed Web of Science ®Google Scholar
• Specchia C, Scott K, Fortina P, et al. (2008). Association of a polymorphic variant of the adiponectin gene with insulin resistance in African Americans. Clin Transl Sci 1:194–9
   PubMed Web of Science ®Google Scholar
• Szopa M, Malczewska-Malec M, Kiec-Wilk B, et al. (2009). Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 46:317–22
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Selvarajah D. (2012). Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28 Suppl 1:8–14
   Web of Science ®Google Scholar
• Tesfaye S. (2011). Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig 2:33–42
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, La Placa S, Di Raimondo D, et al. (2010). Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol 9:50
   PubMed Web of Science ®Google Scholar
• Wang Z, Potter CS, Sundberg JP, et al. (2012). SHARPIN is a key regulator of immune and inflammatory responses. J Cell Mol Med 16:2271–9
   PubMed Web of Science ®Google Scholar
• Wiggin TD, Sullivan KA, Pop-Busui R, et al. (2009). Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58:1634–40
   PubMed Web of Science ®Google Scholar
• Won JC, Kim SS, Ko KS, et al. (2014). Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the Korean diabetes association. Diabetes Metab J 38:25–31
   PubMedGoogle Scholar
• Yamada T, Araki H, Watabe K, et al. (2010). Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice. J Gastroenterol 45:742–9
   PubMed Web of Science ®Google Scholar
• Yang H, Ye E, Si G, et al. (2014). Adiponectin gene polymorphism rs2241766 T/G is associated with response to pioglitazone treatment in type 2 diabetic patients from southern China. PLoS One 9:e112480
   PubMed Web of Science ®Google Scholar
• Zhang C, Zeng X, Li Z, et al. (2015). Immunoglobulin A nephropathy: current progress and future directions. Transl Res 166:134–44
   PubMed Web of Science ®Google Scholar
• Ziegler D, Rathmann W, Dickhaus T, et al. (2008). Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 31:464–9
   PubMed Web of Science ®Google Scholar